HCA Healthcare, Inc.
HCALast close · Oct 16, 2026458.84−9.66 (−2.06%)
Market cap$99.3B
Between Feb 6, 2026 and Aug 26, 2026, HCA Healthcare (HCA) insiders filed 40 Form 4 transactions: 4 sales worth $7.1M in total and no open-market purchase. The largest seller was Berres Jennifer, $2.1M. 36 other filings were grants, exercises or gifts, which say nothing about buying or selling.
40
0
4
0
Form 4 transactions
| Date | Insider | Title | Code | Plan | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| 2026-08-26 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | J | 7,769 | 429.00 | $3.3M | |
| 2026-05-07 | Marks Mike A | EVP and CFO | G | 3,336 | 0.00 | $0 | |
| 2026-05-07 | Marks Mike A | EVP and CFO | G | 3,336 | 0.00 | $0 | |
| 2026-04-28 | Frist William R | Director, 10% Owner | A | 809 | 0.00 | $0 | |
| 2026-04-28 | FRIST THOMAS F III | Director, 10% Owner | A | 1,041 | 0.00 | $0 | |
| 2026-04-28 | Smith Andrea B | Director | A | 509 | 0.00 | $0 | |
| 2026-04-28 | Riley Wayne Joseph | Director | A | 509 | 0.00 | $0 | |
| 2026-04-28 | MICHELSON MICHAEL W | Director | A | 925 | 0.00 | $0 | |
| 2026-04-28 | Johnston Hugh F | Director | A | 809 | 0.00 | $0 | |
| 2026-04-28 | DEPARLE NANCY ANN | Director | A | 509 | 0.00 | $0 | |
| 2026-04-28 | CHIDSEY JOHN | Director | A | 809 | 0.00 | $0 | |
| 2026-02-13 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | M | 5,000 | 236.61 | $1.2M | |
| 2026-02-13 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | F | 3,306 | 540.29 | $1.8M | |
| 2026-02-18 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | S | 1,694 | 533.37 | $903,536.7 | |
| 2026-02-13 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | M | 5,000 | 0.00 | $0 | |
| 2026-02-10 | Wyatt Christopher F. | SVP & Controller | F | 1,034 | 502.05 | $519,119.7 | |
| 2026-02-10 | Wyatt Christopher F. | SVP & Controller | A | 3,350 | 0.00 | $0 | |
| 2026-02-11 | Wyatt Christopher F. | SVP & Controller | S | 4,000 | 505.00 | $2.0M | |
| 2026-02-10 | Rossitto Erica | SVP & Chief Nurse Executive | A | 1,676 | 0.00 | $0 | |
| 2026-02-10 | Rossitto Erica | SVP & Chief Nurse Executive | F | 418 | 502.05 | $209,856.9 | |
| 2026-02-10 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | A | 8,372 | 0.00 | $0 | |
| 2026-02-10 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | F | 3,006 | 502.05 | $1.5M | |
| 2026-02-10 | Marks Mike A | EVP and CFO | F | 1,690 | 502.05 | $848,464.5 | |
| 2026-02-10 | Marks Mike A | EVP and CFO | A | 5,026 | 0.00 | $0 | |
| 2026-02-10 | HAZEN SAMUEL N | CEO | A | 54,934 | 0.00 | $0 | |
| 2026-02-10 | HAZEN SAMUEL N | CEO | F | 21,323 | 502.05 | $10.7M | |
| 2026-02-10 | Foster Jon M | EVP and COO | A | 15,696 | 0.00 | $0 | |
| 2026-02-10 | Foster Jon M | EVP and COO | F | 5,888 | 502.05 | $3.0M | |
| 2026-02-10 | Cuffe Michael S. | EVP and Chief Clinical Officer | A | 9,628 | 0.00 | $0 | |
| 2026-02-10 | Cuffe Michael S. | EVP and Chief Clinical Officer | F | 3,501 | 502.05 | $1.8M | |
| 2026-02-10 | Berres Jennifer | SVP & Chief Human Res. Officer | A | 7,116 | 0.00 | $0 | |
| 2026-02-10 | Berres Jennifer | SVP & Chief Human Res. Officer | F | 2,515 | 502.05 | $1.3M | |
| 2026-02-11 | Berres Jennifer | SVP & Chief Human Res. Officer | S | 4,010 | 503.00 | $2.0M | |
| 2026-02-11 | Berres Jennifer | SVP & Chief Human Res. Officer | S | 4,010 | 526.16 | $2.1M | |
| 2026-02-06 | FRIST THOMAS F JR | 10% Owner | J | 37M | — | — | |
| 2026-02-06 | FRIST THOMAS F JR | 10% Owner | J | 37M | — | — | |
| 2026-02-06 | Frist William R | Director, 10% Owner | J | 37M | — | — | |
| 2026-02-06 | Frist William R | Director, 10% Owner | J | 37M | — | — | |
| 2026-02-06 | FRIST THOMAS F III | Director, 10% Owner | J | 37M | — | — | |
| 2026-02-06 | FRIST THOMAS F III | Director, 10% Owner | J | 37M | — | — |
Codes are the SEC's: P open-market purchase, S open-market sale; M exercise, F tax withholding, A grant and G gift are routine. A 10b5-1 flag means the trade ran under a plan adopted in advance. Method notes in where the numbers come from.